Accu-check inform II glucose control and solutions exercise option 1
Active Awarded Last action
- Contract number
- 36C25724N0385
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $130,584
Award facts
- Contract value 40% obligated
-
- $195,876.00 Current, with exercised options
- $326,460.00 Potential, with all options
- Completion date 47% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $65,292 | |
| Exercise an Option | $65,292 | |
| Original award | $65,292 |
About this award
Roche Diagnostics Corporation has been awarded a $326,460 firm fixed-price delivery order by Veterans Integrated Service Network 17 (VISN 17) for Accu-Check Inform II glucose control and solutions, with an ultimate completion date of June 30, 2029. This delivery order, issued without set-aside designation, supports point-of-care glucose testing capabilities across the Veterans Health Administration. The contract is a child award under Roche's parent General Services Administration Schedule contract for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII), which enables the VA and other federal healthcare agencies to procure diagnostic products through pre-negotiated pricing and established terms.
Roche Diagnostics Corporation maintains an extensive federal contracting presence across multiple VISN regions and the Defense Health Agency, supplying comprehensive diagnostic solutions including molecular analyzers, histology staining systems, and point-of-care testing devices. This VISN 17 award reflects the sustained demand for Roche's specialized diagnostic capabilities within the Veterans Health Administration, which relies on the company's products to support laboratory and clinical testing services across its healthcare network. The award is one of multiple active contracts Roche maintains with various VISNs and federal healthcare agencies through 2030.
Quick answers
Who was awarded contract 36C25724N0385?
36C25724N0385 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 17 (Veterans Health Administration) on July 3, 2024.
How much is contract 36C25724N0385 worth?
The government has obligated $130,584 on 36C25724N0385. Its current value, with exercised options, is $195,876. Its potential value, with all options, is $326,460.
Is contract 36C25724N0385 an order under another contract?
Yes. 36C25724N0385 is a delivery order under 36F79722D0128, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25724N0385 competed?
The extent of competition for 36C25724N0385 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award